This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
$0.05000
Share price
0.00%
Change (1 day)
-97.22%
Change (1 year)
Revenue for Amyris (AMRS)
Revenue in 2023 (TTM): $0.26 Billion USD
According to Amyris's latest financial reports the company's current revenue (TTM 
) is $0.26 Billion USD. In 2022 the company made a revenue of $0.26 Billion USD a decrease over the revenue in the year 2021 that were of $0.34 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amyris from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.26 B | -0.6% |
| 2022 | $0.26 B | -21.06% |
| 2021 | $0.34 B | 97.43% |
| 2020 | $0.17 B | 13.49% |
| 2019 | $0.15 B | 85.96% |
| 2018 | $82.03 M | -42.81% |
| 2017 | $0.14 B | 85.83% |
| 2016 | $77.19 M | 126.02% |
| 2015 | $34.15 M | -21.08% |
| 2014 | $43.27 M | 5.24% |
| 2013 | $41.11 M | -44.2% |
| 2012 | $73.69 M | -49.86% |
| 2011 | $0.14 B | 83.03% |
| 2010 | $80.31 M | 24.31% |
| 2009 | $64.6 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | $11.48 B | 4,181.54% | 🇺🇸 USA |
 | $5.37 B | 1,904.89% | 🇺🇸 USA |
 | $0.24 B | -9.28% | 🇺🇸 USA |
 | $2.45 B | 816.71% | 🇺🇸 USA |
 | $16.91 M | -93.69% | 🇺🇸 USA |
 | $12.38 B | 4,517.83% | 🇺🇸 USA |